← Back to All US Stocks

Sol-Gel Technologies Ltd. (SLGL) Fundamental Analysis & AI Grade 2026

SLGL Nasdaq Pharmaceutical Preparations L3 CIK: 0001684693
Recently Updated • Analysis: Jul 12, 2026 • SEC Data: 2026-07-12

Sol-Gel Technologies Ltd. (SLGL) Financial Metrics & Key Ratios

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

SLGL Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

SLGL vs Healthcare Sector: How Sol-Gel Technologies Ltd. Compares

How Sol-Gel Technologies Ltd. compares to Healthcare sector averages

Net Margin
SLGL 0.0%
vs
Sector Avg 12.0%
SLGL Sector
ROE
SLGL 0.0%
vs
Sector Avg 15.0%
SLGL Sector
Current Ratio
SLGL 0.0x
vs
Sector Avg 2.0x
SLGL Sector
Debt/Equity
SLGL 0.0x
vs
Sector Avg 0.6x
SLGL Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Sol-Gel Technologies Ltd. Stock Overvalued? SLGL Valuation Analysis 2026

Based on fundamental analysis, Sol-Gel Technologies Ltd. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
N/A
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Sol-Gel Technologies Ltd. Balance Sheet: SLGL Debt, Cash & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

SLGL Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

SLGL SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Sol-Gel Technologies Ltd. (CIK: 0001684693)

📋 Recent SEC Filings

Date Form Document Action
Jul 10, 2026 4 xslF345X06/ownership.xml View →
Jul 2, 2026 4 xslF345X06/ownership.xml View →
May 22, 2026 4 xslF345X06/ownership.xml View →
May 14, 2026 4 xslF345X06/ownership.xml View →
Mar 24, 2026 4 xslF345X06/ownership.xml View →

Frequently Asked Questions about SLGL

What is the AI rating for SLGL?

Sol-Gel Technologies Ltd. (SLGL) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.

What are SLGL's key strengths?

Claude: Analysis in progress.

What are the risks of investing in SLGL?

Claude: Analysis in progress.

What is SLGL's revenue and growth?

Sol-Gel Technologies Ltd. reported revenue of N/A.

Does SLGL pay dividends?

Sol-Gel Technologies Ltd. does not currently pay dividends.

Where can I find SLGL SEC filings?

Official SEC filings for Sol-Gel Technologies Ltd. (CIK: 0001684693) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is SLGL's EPS?

Sol-Gel Technologies Ltd. has a diluted EPS of $0.00.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.

What is SLGL's fundamental grade?

Based on our AI fundamental analysis in July 2026, Sol-Gel Technologies Ltd. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.

Is SLGL stock overvalued or undervalued?

Valuation metrics for SLGL: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

What is SLGL's AI grade for 2026?

Our dual AI analysis gives Sol-Gel Technologies Ltd. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is SLGL's free cash flow?

Sol-Gel Technologies Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.

How does SLGL compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% CRDO 87% AVGO 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Jul 12, 2026 | Data as of: 2026-07-12 | Powered by Claude AI